Jiangshan Li

Jiangshan Li


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
KLKaifeng Lyu
Kaifeng Lyu
JLJiangshan Li
Jiangshan Li
MCMin Chen
Min Chen
WLWu Li
Wu Li
WZWei Zhang
Wei Zhang
XFXiang Feng
Xiang Feng
Background: This study employs bibliometric methods to comprehensively understand the fundamental structure of research about Autism Spectrum Disorder (ASD) Signaling Pathways by examining key indicators such as nations, institutions, journals, authors, and keywords.Methodology: We utilized the WoScc database to retrieve literature relevant to ASD Signaling Pathways published between 2013 and 2023. Through visual analysis and tools like CiteSpace and VosViewer, we explored nations, institutions, journals, authors, and keywords, thereby constructing relevant networks.Results: 26 The study encompasses 1,396 articles, revealing a consistent increase in publications. The United States, China, and Germany are leading nations in this literature. Regarding research institutions, the University of California system and Eric Klann have garnered significant attention due to their substantial contributions to the field of ASD Signaling Pathways. Most relevant research is published in the journal “Molecular Autism.” Research interests are concentrated across various themes, including “elevating neuronal β-catenin levels,” “Tunisian children,” “Fmr1 knockout (KO) mice,” “de novo mutations,” “autistic children,” “local translation,” “propionic acid-induced mouse models,” “neurosystems,” “glucose metabolism,” and “neuronal migration.” Future research may emphasize exploring aspects such as gut microbiota, genes, stress, maternal immune activation, memory, and neurodevelopmental disorders of ASD.Conclusion: This study, through bibliometric analysis of key indicators such as nations, institutions, journals, authors, and keywords, provides a comprehensive overview of the current state of research on ASD Signaling Pathways. These investigations predominantly focus on molecular mechanisms, animal model studies, population-based research, and the structure and function of neurosystems. Future research directions are also clearly proposed. First, in-depth research on the genes and neurodevelopmental disorders associated with ASD will continue to reveal the genetic basis and provide support for precise treatments. At the same time, attention to the gut microbiota will help explore its association with ASD, which may provide clues for new treatments. In addition, the relationship between stress and ASD will become the focus of research to understand better the emotional and behavioral characteristics of ASD patients in stressful situations. Maternal immune activation will also be further studied to explore how environmental factors influence the risk and development of ASD. Finally, a deeper understanding of the cognitive functions of patients with ASD, especially memory and learning, will help develop individualized treatment strategies to improve patients’ quality of life. These directions will work together and are expected to provide a more comprehensive understanding of Signaling Pathways research in ASD and provide new ideas and opportunities for future intervention and treatment.

25 January 2022 in Trials
Verified
Journal Article
Open access
PDF file
XFXiang Feng
Xiang Feng
QJQuanrui Jiang
Quanrui Jiang
YZYuxing Zhang
Yuxing Zhang
TLTao Li
Tao Li
WWWei Wei
Wei Wei
JLJiangshan Li
Jiangshan Li
Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by repetitive stereotypical behavior and communication deficits. Currently, it lacks a specific clinical treatment method. Pediatric Tuina is a recent therapy in traditional Chinese medicine (TCM) and has been used to treat children with ASD. Nonetheless, it remains uncommon given the lack of large-scale evidence-based medical studies. This study aims to compare the efficacy of Tuina and conventional treatment in children with ASD. Methods: Eligible children will be randomly assigned to either the pediatric Tuina plus conventional treatment group or to the conventional treatment alone group based on a random table at a ratio of 1:1. The effectiveness of the Tuina intervention for ASD will be evaluated by a third-party organization. The pre- and post-intervention scores on the Childhood Autism Rating Scale comprised the primary outcome, whereas pre- and post-intervention scores on the Autism Treatment Evaluation Checklist were the secondary outcomes to assess improvement in symptoms. Baseline values of the participants will be determined at the time of registration. Outcomes will be evaluated after the 30th treatment session. The follow-up period will last for 6 months after treatment. Discussion: This study will evaluate the effectiveness and safety of Tuina in the treatment of ASD. The results of this study could provide reliable evidence to improve the management of patients with ASD. Trial registration: Chinese Clinical Trial Registry (CHICTR), ChiCTR2000040452. Registered on 28 November 2020.

4 March 2022 in Medicine
Verified
Journal Article
Open access
XFXiang Feng
Xiang Feng
KLKeshang Bd Li
Keshang Bd Li
QJQuanrui Jiang
Quanrui Jiang
YZYuxing Zhang
Yuxing Zhang
ZGZhichao Gong
Zhichao Gong
JLJiangshan Li
Jiangshan Li
Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social communication, social interaction, and restrictive or repetitive behaviors. Traditional Chinese medicine (TCM) has been used in the clinical management of ASD, especially in mainland China, where studies have shown promising efficacy. However, this remains to be further explored and clarified. Therefore, the purpose of this study was to evaluate the effectiveness and safety of conventional treatment-based TCM interventions for ASD. Method: The study will be conducted from January 2022, and the following electronic databases will be searched: China Biological Medicine Database, Chinese Scientific Journals Database, Wan Fang database, and China National Knowledge Infrastructure, the Cochrane Library, Web of Science, PubMed, and EMBASE Database. Only randomized controlled trials of TCM interventions for ASD will be included. The Autism Diagnostic Observation Scale, Autism Diagnostic Interview-Revised, and Childhood Autism Rating Scale will be the primary outcome indicators. The methodological quality of this Bayesian-based network meta-analysis will be performed using the “Risk of Bias” tool. Stata 14.0 and WinBUGS 1.4.3 will be used to analyze the data. In addition, assessment of heterogeneity, inconsistency, subgroups, sensitivity, and publication bias will be conducted using the Cochrane Collaboration's tools. Results: The results of this study will be submitted to a peer-reviewed journal for publication. Conclusion: This study will help patients recover better, provide clinical evidence for practitioners, and promote the use of TCM in ASD interventions.

11 December 2025 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
YCYi-Nan Chen
Yi-Nan Chen
SZSha-Tong Zhao
Sha-Tong Zhao
MHMing-An Hu
Ming-An Hu
WLWu Li
Wu Li
JYJuan Yu
Juan Yu
JLJiangshan Li
Jiangshan Li
Synaptic abnormalities are hallmark pathological features of autism spectrum disorders (ASD), contributing to the behavioral impairments frequently observe

1 May 2025 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
ZGZhichao Gong
Zhichao Gong
YGYinyan Gao
Yinyan Gao
WLWenqi Liu
Wenqi Liu
WLWu Li
Wu Li
XWXinyin Wu
Xinyin Wu
JLJiangshan Li
Jiangshan Li
Purpose: To evaluate whether Jingjin therapy, a distal manual intervention, could accelerate extension dysfunction for non-specific chronic neck pain (NCNP). Patients and Methods: In this single-centre, two-arm randomised controlled trial, we enrolled Chinese patients aged 20– 60 years with active neck extension disorder, regardless of prior exposure to manual therapy. We randomly assigned 160 patients to one of the following two arms: Jingjin therapy or general manual therapy. Both groups underwent six treatment sessions: the first three sessions were administered daily, and the last three sessions were administered every other day. The primary outcome was the between-group difference in the angle of active neck extension after the sixth treatment and 1 week after treatment. A repeated-measures linear mixed-effects model was used to assess between-group differences in outcome indices, with group allocation and treatment time points treated as fixed effects and participants as random effects. Results: The change in the angle of active neck extension from baseline to the sixth treatment session was significant for Jingjin therapy (mean: 29.75° to 51.97°) and general manual therapy (mean: 28.18° to 52.49°). Further, the between-group difference was minimal (mean − 0.26°, 95% confidence interval, − 2.62°, 2.09°) and not statistically significant (P = 0.828). Conclusion: Jingjin therapy for 9 days significantly improved neck extension function in patients with NCNP, with no significant difference compared to general manual therapy. Clinical Trial Registry Id: ChiCTR2300068892. Plain Language Summary: This study evaluated the efficacy of Jingjin therapy, a massage technique employed for the treatment of non-specific chronic neck pain, in comparison with conventional manual therapy in adult populations. The primary objective was to assess whether Jingjin therapy could enhance neck mobility. The findings revealed that both therapeutic modalities were beneficial and exhibited comparable effectiveness. Notably, Jingjin therapy, characterized by its distal intervention site, demonstrated fewer side effects and was more readily accepted by patients. Consequently, Jingjin therapy may represent a viable alternative for the management of chronic neck pain. However, further research is warranted to determine its potential for use in conjunction with other treatment modalities and its efficacy in addressing other types of neck pain.

11 October 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
YZYuxing Zhang
Yuxing Zhang
YCYinan Chen
Yinan Chen
WLWu Li
Wu Li
LTLiya Tang
Liya Tang
JLJiangshan Li
Jiangshan Li
XFXiang Feng
Xiang Feng
Circadian dysfunction is prevalent in neurodevelopmental disorders, particularly in autism spectrum disorder (ASD). A plethora of empirical studies demonstrate a strong correlation between ASD and circadian disruption, suggesting that modulation of circadian rhythms and the clocks could yield satisfactory advancements. Research indicates that circadian dysfunction associated with abnormal neurodevelopmental phenotypes in ASD individuals, potentially contribute to synapse plasticity disruption. Therefore, targeting circadian rhythms may emerge as a key therapeutic approach. In this study, we did a brief review of the mammalian circadian clock, and the correlation between the circadian mechanism and the pathology of ASD at multiple levels. In addition, we highlight that circadian is the target or modulator to participate in the therapeutic approaches in the management of ASD, such as phototherapy, melatonin, modulating circadian components, natural compounds, and chronotherapies. A deep understanding of the circadian clock’s regulatory role in the neurodevelopmental phenotypes in ASD may inspire novel strategies for improving ASD treatment.